[Inhibitory effect of combined bacterin on growth of sarcoma 180 in mice]. 2007

Shu-Mei Li, and Xiao-Ting Luo, and Jin-Hua Ye, and Yue-Ling Xiong, and Lei Yu, and Fu-You Zhong, and Qin Huang
Scientific Research Center, Gannan Medical College, Ganzhou, Jiangxi, 341000, PR China. gnyxylsm@163.com

OBJECTIVE It was reported that the symptoms of tumor patients may be alleviated markedly and even the tumor may be regressed completely after acute infection. Bacterin OK-432 has notable inhibitory effect on the growth of various tumors in animals. At present, OK-432 has been used in clinical immunotherapy for tumors with no other adverse events besides fever and leucocytosis. This study was to investigate the effects of combined bacterin on the serum level of interleukin 12(p70)[IL-12(p70)] and the growth of sarcoma 180 (S180) in mice. METHODS After transplantation of S180, the mice were randomized into 5 groups, and received injection of Staphylococcus aureus, Salmonella typhimurium, Mycobacteria phlei, and combined bacterin containing the 3 bacteria strains, respectively, or received no treatment (blank control). The weight of S180 xenografts, the thymus, and the spleen in mice was measured. The serum level of IL-12(p70) was detected by ELISA. RESULTS The mean weight of S180 tumors was 1.39 g in Staphylococcus aureus group, 1.50 g in Salmonella typhimurium group, 1.36 g in Mycobacteria phlei group, 0.62 g in combined bacterin group, and 2.40 g in blank control group; the differences among the 5 groups were significant (F=66.73, P<0.001). The mean weight of S180 tumors was significantly lower in the 4 bacterin groups than in control group, and significantly lower in combined bacterin group than in the 3 single bacterin groups (q test, P<0.001). The weights of the thymus and the spleen among the 5 groups had no significant difference (F=2.36, P>0.05; F=1.89, P>0.05). The inhibition rate of tumor growth was significantly higher in combined bacterin group than in Staphylococcus aureus, Salmonella typhimurium, and Mycobacteria phlei groups (74.17% vs. 42.08%, 37.50%, and 43.33%, P<0.01). The mean serum level of IL-12(p70) was 19.44 pg/ml in combined bacterin group, 12.41 pg/ml in Staphylococcus aureus group, 10.35 pg/ml in Salmonella typhimurium group, 11.68 pg/ml in Mycobacteria phlei group, and 4.45 pg/ml in control group; the difference among the 5 groups was significant (F=15.76, P<0.0001), but the difference among the 3 single bacterin groups was not significant (q test, P>0.05), while the differences between other groups were significant (q test, P<0.01). CONCLUSIONS The chosen bacterins in this study can induce the mice to produce IL-12(p70) and suppress the growth of S180. The effect of the combined bacterin is much better than the single bacterins.

UI MeSH Term Description Entries
D008297 Male Males
D009168 Mycobacterium phlei A saprophytic bacterium widely distributed in soil and dust and on plants.
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D010844 Picibanil A lyophilized preparation of a low-virulence strain (SU) of Streptococcus pyogenes (S. hemolyticus), inactivated by heating with penicillin G. It has been proposed as a noncytotoxic antineoplastic agent because of its immune system-stimulating activity. NSC-B116209,OK-432,Picibanyl,Streptococcal OK-432,Streptococcal Preparation OK-432,NSC B116209,NSCB116209,OK 432,OK432,Streptococcal OK 432,Streptococcal OK432,Streptococcal Preparation OK 432,Streptococcal Preparation OK432
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial

Related Publications

Shu-Mei Li, and Xiao-Ting Luo, and Jin-Hua Ye, and Yue-Ling Xiong, and Lei Yu, and Fu-You Zhong, and Qin Huang
April 1981, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
Shu-Mei Li, and Xiao-Ting Luo, and Jin-Hua Ye, and Yue-Ling Xiong, and Lei Yu, and Fu-You Zhong, and Qin Huang
January 1978, Neoplasma,
Shu-Mei Li, and Xiao-Ting Luo, and Jin-Hua Ye, and Yue-Ling Xiong, and Lei Yu, and Fu-You Zhong, and Qin Huang
November 1962, Cancer research,
Shu-Mei Li, and Xiao-Ting Luo, and Jin-Hua Ye, and Yue-Ling Xiong, and Lei Yu, and Fu-You Zhong, and Qin Huang
April 1964, The science reports of the research institutes, Tohoku University. Ser. C, Medicine. Tohoku Daigaku,
Shu-Mei Li, and Xiao-Ting Luo, and Jin-Hua Ye, and Yue-Ling Xiong, and Lei Yu, and Fu-You Zhong, and Qin Huang
March 1992, Indian journal of experimental biology,
Shu-Mei Li, and Xiao-Ting Luo, and Jin-Hua Ye, and Yue-Ling Xiong, and Lei Yu, and Fu-You Zhong, and Qin Huang
March 1963, The science reports of the research institutes, Tohoku University. Ser. C, Medicine. Tohoku Daigaku,
Shu-Mei Li, and Xiao-Ting Luo, and Jin-Hua Ye, and Yue-Ling Xiong, and Lei Yu, and Fu-You Zhong, and Qin Huang
January 1982, Cancer research,
Shu-Mei Li, and Xiao-Ting Luo, and Jin-Hua Ye, and Yue-Ling Xiong, and Lei Yu, and Fu-You Zhong, and Qin Huang
October 1972, Gan,
Shu-Mei Li, and Xiao-Ting Luo, and Jin-Hua Ye, and Yue-Ling Xiong, and Lei Yu, and Fu-You Zhong, and Qin Huang
March 2005, Biological & pharmaceutical bulletin,
Shu-Mei Li, and Xiao-Ting Luo, and Jin-Hua Ye, and Yue-Ling Xiong, and Lei Yu, and Fu-You Zhong, and Qin Huang
April 2014, Anticancer research,
Copied contents to your clipboard!